PlainRecalls
FDA Drug Moderate Class II Terminated

Metronidazole Injection, USP, 500 mg/100 mL, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-001-24

Reported: April 5, 2017 Initiated: March 10, 2017 #D-0616-2017

Product Description

Metronidazole Injection, USP, 500 mg/100 mL, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-001-24

Reason for Recall

Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

Details

Recalling Firm
Claris Lifesciences Inc
Units Affected
72072 units
Distribution
Nationwide
Location
North Brunswick, NJ

Frequently Asked Questions

What product was recalled?
Metronidazole Injection, USP, 500 mg/100 mL, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-001-24. Recalled by Claris Lifesciences Inc. Units affected: 72072 units.
Why was this product recalled?
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 5, 2017. Severity: Moderate. Recall number: D-0616-2017.